{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/community-engagement-in-hiv-tb-and-vulnerable-groups”
},
“@id”: “https://www.clinicalstudies.in/community-engagement-in-hiv-tb-and-vulnerable-groups”,
“headline”: “SOP for Community Engagement in HIV, TB and Vulnerable Groups”,
“name”: “SOP for Community Engagement in HIV, TB and Vulnerable Groups”,
“description”: “Detailed SOP describing sponsor, investigator, and site responsibilities for community engagement in HIV, TB, and vulnerable group clinical trials conducted in South Africa to ensure ethical compliance and participant protection.”,
“keywords”: “community engagement SOP South Africa, SOP for HIV trial community engagement, SOP for TB trial participant engagement, SOP for vulnerable population engagement, SAHPRA ethics requirements community, SOP for informed consent support South Africa, SOP for trial outreach programs, SOP for stakeholder engagement clinical trials, SOP for cultural considerations HIV TB trials, SOP for ethics in vulnerable group trials, SOP for trial awareness South Africa, SOP for sponsor community engagement, SOP for CRO engagement responsibilities, SOP for patient advocacy involvement, SOP for site engagement activities South Africa, SOP for investigator community responsibilities, SOP for recruitment in vulnerable groups South Africa, SOP for EC community approval South Africa, SOP for engagement documentation SOP, SOP for ethics monitoring community trials, SOP for capacity building HIV TB trials, SOP for compliance inspection readiness South Africa, SOP for communication with local communities, SOP for subject protection vulnerable populations, SOP for trial governance community engagement”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Community Engagement in HIV, TB and Vulnerable Groups SOP

Purpose

This SOP defines procedures for community engagement in clinical trials involving HIV, TB, and vulnerable populations in South Africa. It ensures participants are informed, culturally respected, and ethically protected, in line with SAHPRA, Ethics Committee (EC), and Good Clinical Practice (GCP) requirements.

Scope

This SOP applies to all sponsor-led and investigator-initiated trials in South Africa that involve vulnerable populations, including people living with HIV, TB patients, and socioeconomically disadvantaged communities. It covers engagement planning, outreach, ethics review, community advisory board (CAB) interactions, and ongoing monitoring.

Responsibilities

• Sponsor: Ensures community engagement strategies are developed and approved before trial initiation.
• Principal Investigator (PI): Implements site-level engagement and maintains communication with local communities.
• Community Advisory Board (CAB): Provides input on cultural sensitivity and trial acceptability.
• Clinical Research Coordinator (CRC): Facilitates community education sessions and maintains engagement logs.
• Regulatory Affairs (RA): Submits engagement plans to EC for approval.
• Quality Assurance (QA): Audits community engagement activities for compliance.

Accountability

The Sponsor’s Head of Clinical Operations is accountable for ensuring community engagement strategies are aligned with regulatory expectations. The PI is accountable for ensuring ongoing communication with trial participants and vulnerable groups.

Procedure

1. Development of Community Engagement Plan

1. Draft a Community Engagement Plan outlining objectives, stakeholders, and methods of engagement.
2. Submit the plan to EC for approval before trial initiation.
3. Maintain plan in TMF and update as required.

2. Formation of Community Advisory Board (CAB)

1. Identify and recruit members from local communities, advocacy groups, and healthcare representatives.
2. Define CAB terms of reference and meeting schedules.

3. Community Outreach Activities

1. Conduct pre-trial sensitization workshops in local languages.
2. Provide culturally appropriate educational materials.
3. Document community questions and feedback in Outreach Log.

4. Ongoing Engagement During Trial

1. Hold quarterly CAB meetings to discuss trial progress and concerns.
2. Maintain transparent communication with participants regarding safety updates and trial outcomes.

5. Ethics Oversight

1. Submit records of community engagement activities to ECs periodically.
2. Address EC feedback and update engagement strategies as required.

6. Documentation and Archiving

1. Maintain Engagement Logs, CAB meeting minutes, and Outreach Logs in TMF and ISF.
2. Archive engagement records for at least 15 years or per SAHPRA requirements.

Abbreviations

• SAHPRA: South African Health Products Regulatory Authority
• EC: Ethics Committee
• CAB: Community Advisory Board
• PI: Principal Investigator
• CRC: Clinical Research Coordinator
• RA: Regulatory Affairs
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Community Engagement Plan (Annexure-1)
2. Outreach Log (Annexure-2)
3. CAB Meeting Minutes (Annexure-3)

References

• SAHPRA — Clinical Trials
• ICH E6(R2) Good Clinical Practice
• Office for Human Research Protections (OHRP)

Version: 1.0

Approval

Annexures

Annexure-1: Community Engagement Plan

Annexure-2: Outreach Log

Annexure-3: CAB Meeting Minutes

Revision History

For more SOPs visit: Pharma SOP.